Cart
0

Allergy Treatment Market by Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs and Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Get 20% Free Customization In This Report
LI_183541
Pages: 220
Oct 2018 | 1412 Views
 
Author's : Kavita Joshi & Onkar Sumant
Tables: 108
Charts: 60
 

Allergy Treatment Market Overview :

An allergy is a condition caused by hypersensitivity of the immune system to typically harmless substances, often referred to as allergens, in the environment. Allergens can include aeroallergens such as dust mite, mold, tree weed, grass pollen, milk, egg, soy, wheat, and others. These allergens can cause various allergic disease conditions including hay fever or allergic rhinitis, asthma, atopic dermatitis, and others. The major symptoms of allergic reactions include itching in the nose, roof of the mouth, throat, or eyes as well as sneezing, stuffy nose (congestion), teary eyes, and others. In addition, food allergies can cause symptoms such as vomiting, diarrhea, or respiratory symptoms, after ingestion of an allergen. According to the WHO, allergies are the fourth largest global pathology condition after cancer, AIDS, and cardiovascular diseases.

The major key factors that drive the global allergy treatment market include significant increase in the prevalence of allergic diseases, rise in preferences toward over-the-counter drugs for allergy treatment, and surge in self-medication in consumers. However, increased usage of biosimilars, and safety & efficacy concerns regarding the side effects associated with vigorous consumption of anti-allergy drugs are anticipated to hamper the growth of the allergy treatment market. On the contrary, increased R&D and rise in awareness among healthcare professionals as well as patients regarding immunotherapy for the treatment of allergies are expected to create lucrative opportunities in future.

Get more information on this report: Request Sample Pages

Type segment review

Based on type, the allergy treatment market is bifurcated into eye allergy, food allergy, skin allergy, asthma, rhinitis, and others. The rhinitis allergy segment was the highest contributor to the market in 2017, and is anticipated to maintain its dominance throughout the forecast period. This was attributed to the increase in prevalence of allergic rhinitis across the globe. For instance, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2017, around 400 million people suffered from rhinitis worldwide.

Get more information on this report: Request Sample Pages

Treatment segment review

Based on treatment, the allergy treatment market is classified into anti-allergy drugs and immunotherapy. The anti-allergy drugs segment accounted for the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the convenience of self-administration, compactness, and easy manufacturing of oral dosage forms.

Get more information on this report: Request Sample Pages

Geography segment review

Based on region, the allergy treatment market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2017, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. However, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025.

The report provides a comprehensive analysis of the leading companies operating in the global market such as GlaxoSmithKline, ALK-Abelló A/S, Sallergenes Greer, Allergy Therapeutics, Sanofi SA, Johnson & Johnson, Merck Co. In, Merck KGaA, F. Hoffmann-La Roche AG, and Allergan plc.

Key Benefits for Allergy Treatment Market :

  • The study provides an in-depth analysis of the global allergy treatment market with the current trends and future estimations to elucidate the imminent investment pockets.

  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.

  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

  • An extensive analysis of the key segments of the industry helps understand the trends in the global allergy treatment market.

  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Allergy Treatment Key Market Segments :

By Type

  • Eye Allergy

  • Skin Allergy

  • Food Allergy

  • Asthma

  • Rhinitis

  • Others

By Treatment

  • Anti-Allergy Drugs

  • Immunotherapy

By Dosage Form

  • Oral

  • Inhalers

  • Intranasal

  • Others

By Distribution Channels

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Retailers

  • Others

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • France

    • Germany

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • LAMEA

    • Saudi Arabia

    • South Africa

    • Brazil

    • Turkey

    • Rest of LAMEA

 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. The rising importance for self-medication
3.5.1.2. Increase in incidence of food allergies across the globe
3.5.1.3. Increased investment by the manufacturers on the development of novel allergic treatments

3.5.2. Restraints

3.5.2.1. Rise in preference towards the use of biosimilars
3.5.2.2. Low awareness of allergy immunotherapy (AIT) among patients

3.5.3. Opportunity

3.5.3.1. Innovative developments in the field of immunotherapy

Chapter: 4: ALLERGY TREATMENT MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Eye allergy

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Rhinitis

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Asthma

4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Skin Allergy

4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Food Allergies

4.6.1. Key trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Other Allergies

4.7.1. Key trends and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

Chapter: 5: ALLERGY TREATMENT MARKET, BY TREATMENT

5.1. Overview

5.1.1. Market size and forecast

5.2. Anti-Allergy Drugs

5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Antihistamines

5.2.3.1. Market size and forecast

5.2.4. Corticosteroids

5.2.4.1. Market size and forecast

5.2.5. Decongestants

5.2.5.1. Market size and forecast

5.2.6. Other Drugs

5.2.6.1. Market size and forecast

5.3. Immunotherapy

5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.3.3. Subcutaneous Immunotherapy (SCIT)

5.3.3.1. Market size and forecast

5.3.4. Sun-Lingual Immunotherapy (SLIT)

5.3.4.1. Market size and forecast

Chapter: 6: ALLERGY TREATMENT MARKET, BY DOSAGE FORM

6.1. Overview

6.1.1. Market size and forecast

6.2. Oral

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Inhalers

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Intranasal

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Others

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

Chapter: 7: ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL

7.1. Overview

7.1.1. Market size and forecast

7.2. Retail pharmacies

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Hospital Pharmacies

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Online Retailers

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

7.5. Others

7.5.1. Market size and forecast
7.5.2. Market analysis, by country

Chapter: 8: ALLERGY TREATMENT MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key trends and opportunities

8.2.2. North America market size and forecast, by country

8.2.2.1. U.S. market size and forecast, by type
8.2.2.2. U.S. market size and forecast, by treatment
8.2.2.3. U.S. market size and forecast, by dosage form
8.2.2.4. U.S. market size and forecast, by distribution channel
8.2.2.5. Canada market size and forecast, by type
8.2.2.6. Canada market size and forecast, by treatment
8.2.2.7. Canada market size and forecast, by dosage form
8.2.2.8. Canada market size and forecast, by distribution channel
8.2.2.9. Mexico market size and forecast, by type
8.2.2.10. Mexico market size and forecast, by treatment
8.2.2.11. Mexico market size and forecast, by dosage form
8.2.2.12. Mexico market size and forecast, by distribution channel

8.2.3. North America market size and forecast, by type
8.2.4. North America market size and forecast, by treatment
8.2.5. North America market size and forecast, by dosage form
8.2.6. North America market size and forecast, by distribution channel

8.3. Europe

8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country

8.3.2.1. Germany market size and forecast, by type
8.3.2.2. Germany market size and forecast, by treatment
8.3.2.3. Germany market size and forecast, by dosage form
8.3.2.4. Germany market size and forecast, by distribution channel
8.3.2.5. UK market size and forecast, by type
8.3.2.6. UK market size and forecast, by treatment
8.3.2.7. UK market size and forecast, by dosage form
8.3.2.8. UK market size and forecast, by distribution channel
8.3.2.9. France market size and forecast, by type
8.3.2.10. France market size and forecast, by treatment
8.3.2.12. France market size and forecast, by dosage form
8.3.2.13. France market size and forecast, by distribution channel
8.3.2.14. Rest of Europe market size and forecast, by Type
8.3.2.15. Rest of Europe market size and forecast, by treatment
8.3.2.16. Rest of Europe market size and forecast, by dosage form
8.3.2.17. Rest of Europe market size and forecast, by distribution channel

8.3.3. Europe market size and forecast, by type
8.3.4. Europe market size and forecast, by treatment
8.3.5. Europe market size and forecast, by dosage form
8.3.6. Europe market size and forecast, by distribution channel

8.4. Asia-Pacific

8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

8.4.2.1. Japan market size and forecast, by type
8.4.2.2. Japan market size and forecast, by treatment
8.4.2.3. Japan market size and forecast, by dosage form
8.4.2.4. Japan market size and forecast, by distribution channel
8.4.2.5. China market size and forecast, by type
8.4.2.6. China market size and forecast, by treatment
8.4.2.7. China market size and forecast, by dosage form
8.4.2.8. China market size and forecast, by distribution channel
8.4.2.9. India market size and forecast, by type
8.4.2.10. India market size and forecast, by treatment
8.4.2.11. India market size and forecast, by dosage form
8.4.2.12. India market size and forecast, by distribution channel
8.4.2.13. Australia market size and forecast, by type
8.4.2.14. Australia market size and forecast, by treatment
8.4.2.15. Australia market size and forecast, by dosage form
8.4.2.16. Australia market size and forecast, by distribution channel
8.4.2.17. South Korea market size and forecast, by type
8.4.2.18. South Korea market size and forecast, by treatment
8.4.2.19. South Korea market size and forecast, by dosage form
8.4.2.20. South Korea market size and forecast, by distribution channel
8.4.2.21. Rest of Asia-Pacific market size and forecast, by type
8.4.2.22. Rest of Asia-Pacific market size and forecast, by treatment
8.4.2.23. Rest of Asia-Pacific market size and forecast, by dosage form
8.4.2.24. Rest of Asia-Pacific market size and forecast, by distribution channel

8.4.3. Asia-Pacific market size and forecast, by type
8.4.4. Asia-Pacific market size and forecast, by treatment
8.4.5. Asia-Pacific market size and forecast, by dosage form
8.4.6. Asia-Pacific market size and forecast, by distribution channel

8.1. LAMEA

8.1.1. Key market trends and opportunities
8.1.2. LAMEA market size and forecast, by country

8.1.2.1. Brazil market size and forecast, by type
8.1.2.2. Brazil market size and forecast, by treatment
8.1.2.3. Brazil market size and forecast, by dosage form
8.1.2.4. Brazil market size and forecast, by distribution channel
8.1.2.5. South Africa market size and forecast, by type
8.1.2.6. South Africa market size and forecast, by treatment
8.1.2.7. South Africa market size and forecast, by dosage form
8.1.2.8. South Africa market size and forecast, by distribution channel
8.1.2.9. Saudi Arabia market size and forecast, by type
8.1.2.10. Saudi Arabia market size and forecast, by treatment
8.1.2.11. Saudi Arabia market size and forecast, by dosage form
8.1.2.12. Saudi Arabia market size and forecast, by distribution channel
8.1.2.13. Turkey market size and forecast, by type
8.1.2.14. Turkey market size and forecast, by treatment
8.1.2.15. Turkey market size and forecast, by dosage form
8.1.2.16. Turkey market size and forecast, by distribution channel
8.1.2.17. Rest of LAMEA market size and forecast, by type
8.1.2.18. Rest of LAMEA market size and forecast, by treatment
8.1.2.19. Rest of LAMEA market size and forecast, by dosage form
8.1.2.20. Rest of LAMEA market size and forecast, by distribution channel

8.1.3. LAMEA market size and forecast, by type
8.1.4. LAMEA market size and forecast, by treatment
8.1.5. LAMEA market size and forecast, by dosage form
8.1.6. LAMEA market size and forecast, by distribution channel

Chapter: 9: COMPANY PROFILES

9.1. Merck KGaA (Allergopharma)

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments

9.2. GlaxoSmithKline plc

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance

9.3. F. Hoffmann-La Roche Ltd. (Genentech Inc.)

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. Johnson & Johnson

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. Allergy Therapeutics plc

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance

9.6. AALK-Abello A/S

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments

9.7. Sanofi SA

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments

9.8. Stallergenes Greer plc

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. Allergan Plc.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance

9.10. Merck & Co. Inc.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance

LIST OF TABLES

TABLE 01. GLOBAL ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 02. GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 03. GLOBAL RHINITIS ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL ASTHMA ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL SKIN ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 06. GLOBAL FOOD ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. GLOBAL OTHER ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 08. GLOBAL ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 09. GLOBAL ALLERGY TREATMENT MARKET, FOR ANTI-ALLERGY DRUGS, BY REGION, 20172025 ($MILLION)
TABLE 10. GLOBAL IMMNUNOTHERAPY ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 12. ALLERGY TREATMENT MARKET, FOR ORAL DOSGE FORM, BY REGION, 20172025 ($MILLION)
TABLE 13. ALLERGY TREATMENT MARKET, FOR INHALERS, BY REGION, 20172025 ($MILLION)
TABLE 14. INTRANASAL MARKET, BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHER DOSAGE FORMBY REGION, 20172025 ($MILLION)
TABLE 16. GLOBAL ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 17. GLOBAL ALLERGY TREATMENT MARKET, FOR RETAIL PHARMACIES BY REGION, 20172025 ($MILLION)
TABLE 18. GLOBAL ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 20172025 ($MILLION)
TABLE 19. GLOBAL ALLERGY TREATMENT MARKET, FOR ONLINE RETAILERS, BY REGION, 20172025 ($MILLION)
TABLE 20. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHERS BY REGION, 20172025 ($MILLION)
TABLE 21. GLOBAL ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 22. NORTH AMERICA ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 23. U.S. ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 24. U.S. ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 25. U.S. ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 26. U.S. ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 27. CANADA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 28. CANADA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 29. CANADA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 30. CANADA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 31. MEXICO ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 32. MEXICO ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 33. MEXICO ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 34. MEXICO ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 35. NORTH AMERICA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 36. NORTH AMERICA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 37. NORTH AMERICA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 38. NORTH AMERICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL 20172025 ($MILLION)
TABLE 39. EUROPE ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 40. GERMANY ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 41. GERMANY ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 42. GERMANY ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 43. GERMANY ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 44. UK ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 45. UK ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 46. UK ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 47. UK ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 48. FRANCE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 49. FRANCE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 50. FRANCE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 51. FRANCE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 52. REST OF EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 53. REST OF EUROPE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 54. REST OF EUROPE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 55. REST OF EUROPE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 56. EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 57. EUROPE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 58. EUROPE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 59. EUROPE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 60. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 61. JAPAN ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 62. JAPAN ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 63. JAPAN ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 64. JAPAN ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 65. CHINA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 66. CHINA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 67. CHINA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 68. CHINA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 69. INDIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 70. INDIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 71. INDIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 72. INDIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 73. AUSTRALIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 74. AUSTRALIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 75. AUSTRALIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 76. AUSTRALIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 77. EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 78. SOUTH KOREA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 79. SOUTH KOREA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 80. SOUTH KOREA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 85. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 86. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 87. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 88. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 89. LAMEA ALLERY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 90. BRAZIL ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 91. BRAZIL ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 92. BRAZIL ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 93. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 94. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 95. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 96. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 97. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 98. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 99. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 100. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 101. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 102. TURKEY ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 103. TURKEY ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 104. TURKEY ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 105. TURKEY ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 106. REST OF LAMEA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 107. REST OF LAMEA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 108. REST OF LAMEA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 109. REST OF LAMEA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 110. LAMEA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 111. LAMEA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 112. LAMEA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 113. LAMEA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 114. MERCK: COMPANY SNAPSHOT
TABLE 115. MERCK: OPERATING SEGMENTS
TABLE 116. MERCK: PRODUCT PORTFOLIO
TABLE 117. GSK: COMPANY SNAPSHOT
TABLE 118. GSK: OPERATING SEGMENTS
TABLE 119. GSK: PRODUCT PORTFOLIO
TABLE 120. ROCHE: COMPANY SNAPSHOT
TABLE 121. ROCHE: OPERATING SEGMENTS
TABLE 122. ROCHE: PRODUCT PORTFOLIO
TABLE 123. J&J: COMPANY SNAPSHOT
TABLE 124. J&J: OPERATING SEGMENTS
TABLE 125. J & J: PRODUCT PORTFOLIO
TABLE 126. ALLERGY THERAPEUTICS: COMPANY SNAPSHOT
TABLE 127. ALLERGY THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 128. ALK: COMPANY SNAPSHOT
TABLE 129. ALK: OPERATING SEGMENTS
TABLE 130. ALK: PRODUCT PORTFOLIO
TABLE 131. SANOFI: COMPANY SNAPSHOT
TABLE 132. SANOFI: OPERATING SEGMENTS
TABLE 133. SANOFI: PRODUCT PORTFOLIO
TABLE 134. STALLERGENES: COMPANY SNAPSHOT
TABLE 135. STALLERGENES: OPERATING SEGMENTS
TABLE 136. STALLERGENES: PRODUCT PORTFOLIO
TABLE 137. ALLERGAN: COMPANY SNAPSHOT
TABLE 138. ALLERGAN: OPERATING SEGMENTS
TABLE 139. ALLERGAN: PRODUCT PORTFOLIO
TABLE 140. MERCK: COMPANY SNAPSHOT
TABLE 141. MERCK: OPERATING SEGMENTS
TABLE 142. MERK: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. ALLERGY TREATMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 06. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTION
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS, 2017
FIGURE 12. GLOBAL ALLERGY TREATMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF RHINITIS ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ASTHMA ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SKIN ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FOOD ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF OTHER ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR ANTI-ALERGY DRUGS BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. GLOBAL ALLERGY TREATMENT MARKET FOR ANTIHISTAMINES, 20172025 ($MILLION)
FIGURE 21. GLOBAL ALLERGY TREATMENT MARKET FOR CORTICOSTEROIDS, 20172025 ($MILLION)
FIGURE 22. GLOBAL ALLERGY TREATMENT MARKET FOR DECONGESTANTS, 20172025 ($MILLION)
FIGURE 23. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR IMMUOTHERAPY BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. GLOBAL ALLERGY TREATMENT MARKET FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 26. GLOBAL ALLERGY TREATMENT MARKET FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR ORAL DOSAGE FORM, BY COUNTRY, 2017 & 2025 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR INHALER, BY COUNTRY, 2017 & 2025 (%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR INTRANASAL, BY COUNTRY, 2017 & 2025 (%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR RETAIL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR ONLINE RETAILERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 34. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 35. MERCK: REVENUE, 20152017 ($MILLION)
FIGURE 36. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. GSK: NET SALES, 20152017 ($MILLION)
FIGURE 39. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 42. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. J&J: NET SALES, 20152017 ($MILLION)
FIGURE 44. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46. ALLERGY THERAPEUTICS: NET SALES, 20152017 ($MILLION)
FIGURE 47. ALK: NET SALES, 20152017 ($MILLION)
FIGURE 48. ALK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 49. ALK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 50. SANOFI: NET SALES, 20152017 ($MILLION)
FIGURE 51. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 52. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 53. STALLERGENES: REVENUE, 20152017 ($MILLION)
FIGURE 54. STALLERGENES: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 55. STALLERGENES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 56. ALLERGAN: NET SALES, 20152017 ($MILLION)
FIGURE 57. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 58. MERCK: NET SALES, 20152017 ($MILLION)
FIGURE 59. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 60. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

 

Allergy is a hypersensitive reaction by the patient’s immune system in response to certain substances. The substances that stimulate the immune system in response are known as allergens. Different allergens are responsible to cause various types of allergic reactions. Allergy is one of the major health concerns globally. The allergy treatment market has piqued the interest of the healthcare industry due to significant increase in the prevalence of various allergies in the recent years. Among all allergies, rhinitis and asthma are the most prevailing diseases, both in the developing as well as developed economies. However, incidents of food allergies have also been on the rise over the years across the globe.

Based on dosage form, the oral drugs segment generated the highest revenue, owing to the rise in preference among consumers toward oral drug consumption, and ease in its manufacturing process. However, intranasal dosage form is anticipated to grow at the highest CAGR throughout the forecast period.

The allergy treatment market is expected to witness a substantial growth owing to the surge in self-directed consumers and rise in awareness regarding immunotherapy treatment. Increase in traction toward incorporation of immunotherapies for the treatment of various allergies contributes to the market growth. There have been remarkable advancements in the field of immunotherapy, which have enabled key market players to focus on the development of allergen-specific immunotherapies. These factors are expected to boost the growth of the market in near future.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Allergy Treatment Market

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo